03 March 2025
Dr. Nick Bull HPB Surgeon, JHH
Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer
Australian Institute of Health and Welfare. Cancer data in Australia Canberra: Australian Institute of Health and Welfare, 2024 [cited 2025 Mar. 24].
Zhang, Beilei et al. The role of FOLFIRINOX in metastatic pancreatic cancer: a meta-analysis.World journal of surgical oncology vol. 19,1 182. 21 Jun. 2021, doi:10.1186/s12957-021-02291-6
Jacobs, Michelle F, and Elena M Stoffel. Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC). Familial cancer vol. 23,3 (2024): 221-232. doi:10.1007/s10689-024-00372-5
Wei, Kongyuan, and Thilo Hackert. Surgical Treatment of Pancreatic Ductal Adenocarcinoma. Cancers vol. 13,8 1971. 20 Apr. 2021, doi:10.3390/cancers13081971
Ventin, Marco, and Cristina R Ferrone. REDISCOVER the change in surgical management of pancreatic cancer from anatomy to biology. Updates in surgery vol. 76,5 (2024): 1569-1571. doi:10.1007/s13304-024-01956-7
St Joseph's Healthcare Centre, Toronto Patient Pathway, The Whipple Procedure
TVA Surg Toronto Video Atlas of Surgery
Spleen Australia Clinicians Updates in surgery vol. 76,5 (2024): 1569-1571. doi:10.1007/s13304-024-01956-7
Back